SHPH

SHPH

USD

Shuttle Pharmaceuticals Holdings Inc. Common Stock

$2.500+0.020 (0.806%)

即時價格

Healthcare
Drug Manufacturers - Specialty & Generic
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.480

最高

$2.509

最低

$2.245

交易量

0.08M

公司基本面

市值

2.7M

行業

Drug Manufacturers - Specialty & Generic

國家

United States

交易統計

平均交易量

0.22M

交易所

NCM

貨幣

USD

52週範圍

最低 $2.2455當前 $2.500最高 $30.825

相關新聞

AccessWire

Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Every generation has its frontier. For the last century, medicine's remained molecular: genes, proteins, receptors, the invisible mechanics of life. Today, that

查看更多
Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)
AccessWire

Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug discovery has always been its toughest proving ground. Molecules don't follow patterns; they

查看更多
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)
AccessWire

Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)

ROCKVILLE, MD / ACCESS Newswire / October 21, 2025 / Radiation therapy has always been the heavyweight of cancer treatment. It works, but it's a brute. It blasts cancer cells, hoping the good ones can withstand the

查看更多
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
GlobeNewswire

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market

GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company, today

查看更多
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market